Effects of configuration on the myocardial uptake of radioiodinated 3(R)-BMIPP and 3(S)-BMIPP in rats

Journal of Nuclear Medicine

Volumn 38, Issue 9, 1997, Pages 1434-1441

  Lin, Q ^b   Luo, H ^b   Mokler, F ^b   Beets, A L ^b   Ambrose, K R ^b   McPherson, D W ^b   Kropp, J ^b   Knapp Jr , F F ^a  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

^b NONE

Author keywords

3(R) and 3(S) BMIPP; Fatty acid imaging; Iodine 123 BMIPP

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; ALPHA METHYLBENZYLAMINE;

ARTICLE; DRUG TISSUE LEVEL; HEART SCINTISCANNING; ISOMERISM; KINETICS; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANIMALS; FATTY ACIDS; FEMALE; IODINE RADIOISOTOPES; IODOBENZENES; MOLECULAR CONFORMATION; RATS; RATS, INBRED F344; STEREOISOMERISM; TISSUE DISTRIBUTION;

EID: 0030987475     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Knapp FF Jr, Kropp J. Iodine-123-labeled fatty acids for myocardial single-photon emission tomography: current status and future perspectives. Eur J Nucl Med 1995;22:361-368.
2. Knapp FF Jr. Myocardial metabolism of radioiodinated BMIPP ("cardiodine"). J Nucl Med 1995;36:1051-1054.
3. Knapp FF Jr, Franken P, Kropp J. Cardiac SPECT with iodine-123-labeled fatty acids: evaluation of myocardial viability with BMIPP. J Nucl Med 1995;36:1022-1030.
4. Knapp FF Jr, Kropp J, Goodman MM, et al. The development of iodine-123-methyl-branched fatty acids and their applications in nuclear cardiology. Ann Nucl Med 1993;7:1-14.
5. Tamaki N, Kawamoto M, Yonekura Y, et al. Assessment of fatty acid metabolism using iodine-123-branched fatty acid: comparison with positron emission tomography. Ann Nucl Med 1993;7:41-48.
6. De Geeter F, Franken PR, Knapp FF Jr, Bossuyt A. Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means to technetium-99m MIBI and iodine-123 beta-methyl iodophenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283-291.
7. Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994;35:1758-1765.
8. Franken PR, Demoor D, De Sadeleer C, Block P, Bossuyt A. Free fatty acid uptake in myocardium with postischemic dysfunction: comparison with dobutamine echocardiography to predict long-term functional recovery [Abstract]. J Nucl Med 1994;35:50P.
9. Franken PR, Dendale P, Flamen P, Bossuyt A, Knapp FF Jr. Incremental value of combined BMIPP and sestamibi SPECT to predict functional outcome after acute myocardial infraction. In: Proceedings, Nuclear Medicine Today 1996 - Role in Clinical Decision Making. Cessena, Italy, in press.
10. Kropp J, Juergans M, Glaenzer K, Luederitz B, Biersack H-J, Knapp FF Jr. Evaluation of ischemia and myocardial viability in patients with coronary artery disease (CAD) with iodine-123-labeled 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP). Ann Nucl Med 1993;7:93-100.
11. Kropp J, Koehler H, Knapp FF Jr, Biersack H-J. 15-(p-[I-123]iodophenyl)-3-R,S-methylpentadecanoic acid to evaluate ischemia in patients with coronary artery disease [Abstract]. Eur J Nucl Med 1991;18:650.
12. Kropp J, Jorgens M, Glanzer K, Knapp FF Jr, Biersack H-J. Evaluation of ischemia and myocardial viability in patients with CAD with the fatty acid 15-(p-[I-123]-iodophenyl-3-R,S-methylpentadecanoic acid. The First International Congress of Nuclear Cardiology. Cannes, France: 1993.
13. Goodman MM, Kirsch G, Knapp FF Jr. Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substituted α-and β-methyl-branched fatty acids. J Med Chem 1984;27:390-397.
14. Knapp FF Jr, Goodman MM, Ambrose KR, et al. The development of radioiodinated 3-methyl-branched fatty acids for evaluation of myocardial disease by single photon techniques. In: van der Wall EE, ed. Noninvasive Imaging of Cardiac Metabolism. Boston: Martinus Nijhoff Publishers; 1987:159-201.
15. Antar MA. Radiolabeled fatty acids for myocardial studies. In: Spencer RP, ed. New Procedures for Nuclear Medicine. Boca Raton, FL: CRC Press; 1989:95-126.
16. Tamaki N, Tadamura E, Kudoh T, et al. Prognostic value of iodine-123-labeled BMIPP fatty acid analog imaging in patients with myocardial infarction. Eur J Nucl Med 1995;23:272-279.
17. Taki J, Nakajima K, Matsunari I, Bunko H, Taka S, Tonami N, Hisada K. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischemic but viable myocardium: assessment with iodine-123-labeled beta-methyl-branched fatty acid. Eur J Nucl Med 1995;22:1385-1392.
18. Tamaki N, Tadamura E, Kawamoto M, et al. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium. J Nucl Med 1995;36:1974-1980.
19. Kodama K, Igase M, Kazatani Y, Matsuzaki K, Murakami E, Kokubu T. Detection of perioperative coronary vasospasm on iodine-123-MIBG, thallium-201 and iodine-123-BMIPP myocardial SPECT images. J Nucl Med 1995;36:2050-2052.
20. Nishimura T, Uehara T, Shimonagata T, Nagata S, Haze K. Clinical experience of iodine-123-BMIPP myocardial imaging for myocardial infarction and hypertrophic cardiomyopathy. Ann Nucl Med 1993;7:35-40.
21. Kurata C, Tawahara K, Okayama K, Wakabayashi Y, Kobayashi A, Yamazaki N, Kaneko M. Myocardial imaging with radioiodinated beta-methyl-branched fatty acid in cardiomyopathy. Ann Nucl Med 1993;7:27-34.
22. Monta K, Yanagimoto S, Otsuka N, et al. Iodine-123-BMIPP scintigraphy in seven cases with cardiomyopathy. Ann Nucl Med 1993;7:101-107.
23. Buchanan MV, Hettich RL. Fourier transform mass spectrometry of high-mass biomolecules. Anal Chem 1993;65:245A-259A.
24. Knapp FF Jr, Goodman MM, Callahan AP, Kirsch G. Radioiodinated 15-(p-iodophenyl)-3,3-dimethylpentadecanoic acid: a useful new agent to evaluate myocardial fatty acid uptake. J Nucl Med 1986;27:521-531.
25. Stremmel W. Fatty acid uptake by isolated rat heart myocytes represents a carrier-mediated transport process. J Clin Invest 1988;81:844-852.
26. Glatz JFC, van der Vusse GJ, Reneman RS. Protective role of fatty acid-binding protein in ischemic and reperfused heart. Circ Res 1991;68:1490-1491.
27. Lam LKP, Hui RAHF, Jones JB. Enzymes in organic synthesis: stereoselective pig liver esterase catalyzed hydrolyses of 3-substituted glutarate diesters; optimization of enantiomeric excess through a reaction conditions control. J Org Chem 1986;51:2047-2050.
28. Konoike T, Araki Y. Practical synthesis of chiral synthons for the preparation of HMG-CoA reductase inhibitors. J Org Chem 1994;59:7849-7854.
29. Kiratake J, Inagaki M, Yamamoto Y, Oda J. Enaniotropic-group differentiation: catalytic asymmetric ring-opening of prochiral cyclic acid anhydrides with methanol, using chinchona alkaloids. J Chem Soc Perkin Trans 1987;1053-1058.
30. Ambrose KR, Owen BA, Goodman MM, Knapp FF Jr. Evaluation of the metabolism in rat hearts of two new radioiodinated 3-methyl-branched fatty acid myocardial imaging agents. Eur J Nucl Med 1987;2:486-491.
31. Ambrose KR, Owen BA, Callahan AP, Goodman MM, Knapp FF Jr. Effects of fasting on the myocardial subcellular distribution and lipid distribution of terminal p-iodophenyl-substituted fatty acids in rats. Nucl Med Biol 1988;15:695-700.
32. Knapp FF Jr, Goodman MM, Reske SN, et al. Radioiodinated methyl-branched fatty acids: evaluation of catabolites formed in vivo. NucCompact/Eur Am Commun Nucl Med 1990;21:229-231.
33. Kropp J, Ambrose KR, Knapp FF Jr, Nissen HP, Biersack H-J. Incorporation of IPPA and BMIPP fatty acid analogs into complex lipids from isolated rat hearts. Nucl Med Biol 1992;19:283-288.
34. 123I-BMIPP). Eur J Nucl Med 1996;23:383-389.
35. Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of iodine-123-labeled 15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid (BMIPP) in perfused rat hearts. J Nucl Med 1995;36:1043-1050.